An interventional study of Zonisamide in Essential Tremor, sponsored by Loma Linda University. Terminated. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2014-07-17.
Sponsored by Loma Linda University · Not applicable, Interventional, and Treatment
The purpose of this study is to determine if Zonisamide is effective in reducing tremors in patients with Essential Tremor.
The subjects will remain on their usual medication and a baseline assessment using the Fahn Tolosa Marin tremor rating scale will be performed and will be video taped.
257 studies on the registry are indexed under Tremor; 59 are open to participants now.
This study's enrollment of 9 is below the median of 25 across 184 interventional studies indexed under Tremor.
Browse Tremor studies →Loma Linda University is the lead sponsor of 297 studies on the registry; 48 are open to participants now.
Of its 28 completed or terminated interventional studies of FDA-regulated products, 23 (82%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Drug: Zonisamide
100mg tablets once a day for two weeks, then increased to 200mg qhs for two weeks.
Also known as: Zonegran
Tremor Severity
PI has left the institution and we are unable to accurately assess the data from the remaining records.
Time frame: 4 weeks
| Milestone | Zonisamide |
|---|---|
| Started | 9 |
| Completed | 9 |
| Not completed | 0 |
PI has left the institution and we are unable to accurately assess the data from the remaining records.
No measurements were reported for this outcome.
Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Zonisamide | — | 0/9 (0%) | 0/9 (0%) |
•\<=18 years Male/Female Hx essential tremor
| Age, Continuous(Years) | Zonisamide |
|---|---|
| Mean | 66.1 ± 16.33078 |
| Age, Categorical(Participants) | Zonisamide |
|---|---|
| <=18 years | 0 |
| Between 18 and 65 years | 4 |
| >=65 years | 5 |
| Sex: Female, Male(Participants) | Zonisamide |
|---|---|
| Female | 3 |
| Male | 6 |
| Region of Enrollment(participants) | Zonisamide |
|---|---|
| United States | 9 |
No study locations are listed for this record.
This study is terminated, as verified in Jul 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Loma Linda University